• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核和艾滋病毒合并感染成人患者死亡生存时间建模:基于机构的回顾性队列研究。

Modeling Survival Time to Death Among TB and HIV Co-infected Adult Patients: an Institution-Based Retrospective Cohort Study.

机构信息

Department of Statistics, College of Natural and Computational Science, Mizan-Tepi University, Tepi, Ethiopia.

Department of Statistics, College of Natural and Computational Science, Addis Ababa University, Addis Ababa, Ethiopia.

出版信息

J Racial Ethn Health Disparities. 2023 Aug;10(4):1616-1628. doi: 10.1007/s40615-022-01348-w. Epub 2022 Jun 13.

DOI:10.1007/s40615-022-01348-w
PMID:35697902
Abstract

BACKGROUND

Tuberculosis is a serious health threat, particularly for people living with human immunodeficiency virus (HIV), and HIV-positive people are more likely than others to contract the disease. Globally, tuberculosis (TB) is one of the leading causes of death among people living with HIV. The purpose of the current study was to identify factors associated with survival rates of TB/HIV co-infected patients using survival models.

METHODS

A retrospective study was conducted on TB/HIV co-infected adult patients registered and under follow-up at Tepi General Hospital (TGH) and Mizan-Tepi University Teaching Hospital (MTUTH), southwest Ethiopia. All TB/HIV co-infection patients who were registered and under follow-up from 1st January 2015 through 1st January 2020 were considered. The global Schoenfeld test was used to test the proportional hazard (PH) assumption. Various accelerated failure time (AFT) models were compared to determine the best model for the time to death of TB/HIV co-infected patients' data set. Among the most commonly used accelerated failure time models (AFT models), the study used exponential, Weibull, log-logistic, and log-lognormal AFT models. AIC and BIC were used to compare the performance of fitted models. The data were analyzed with the statistical software R.

RESULTS

Of 363 TB/HIV co-infected patients followed for 60 months, 79 (21.8%) died, while the remaining 284 (78.2%) were censored. The overall median survival time was 15.6 months. The proportional hazard assumption was checked and it was violated. In comparison to other models, the lognormal AFT model performed better. The results of the multivariable lognormal AFT model showed that age, residence, substance use, educational status, clinical stages of the disease, cluster of differentiation 4 (CD4 count/mm), functional status, cotrimoxazole prophylactic therapy use (CPT use), and INH were all found to be significant factors, while gender, illness other than TB, and disclosure of status were insignificant variables at 5% level of significance.

CONCLUSION

Current study results revealed that older age, substance use, advanced WHO clinical stages of the disease (stage IV), bedridden functional status, and CD4 less than 200 count/mm were significantly associated with shorter survival time to death of HIV/TB co-infected patients while having advanced educational status, being from urban residence, CPT use, and INH significantly increase the survival time to death of TB/HIV co-infected patients. Patients with TB/HIV co-infection should be given special attention based on these important factors to improve their health and prolong their lives. HIV-positive patients are more likely than others to contract the TB disease. The risk of death among TB/HIV co-infected patients was found to be high. Out of all patients, 79 (21.8%) died. Accelerated failure time models are good alternatives for scenario Cox proportional hazard assumptions not met.

摘要

背景

结核病是一个严重的健康威胁,尤其是对人类免疫缺陷病毒(HIV)感染者而言,HIV 阳性者比其他人更容易感染这种疾病。在全球范围内,结核病(TB)是 HIV 感染者死亡的主要原因之一。本研究的目的是使用生存模型来确定与 TB/HIV 合并感染患者生存率相关的因素。

方法

对埃塞俄比亚西南部的 Tepi 综合医院(TGH)和 Mizan-Tepi 大学教学医院(MTUTH)登记并接受随访的 TB/HIV 合并感染成年患者进行回顾性研究。所有在 2015 年 1 月 1 日至 2020 年 1 月 1 日期间登记并接受随访的 TB/HIV 合并感染者均被纳入研究。采用全球 Schoenfeld 检验来检验比例风险(PH)假设。比较了各种加速失效时间(AFT)模型,以确定用于 TB/HIV 合并感染患者数据集的死亡时间的最佳模型。在最常用的加速失效时间模型(AFT 模型)中,研究使用了指数、威布尔、对数逻辑和对数正态 AFT 模型。AIC 和 BIC 用于比较拟合模型的性能。数据使用 R 统计软件进行分析。

结果

在接受 60 个月随访的 363 例 TB/HIV 合并感染者中,有 79 例(21.8%)死亡,其余 284 例(78.2%)被删失。总的中位生存时间为 15.6 个月。检查了比例风险假设,发现该假设被违反。与其他模型相比,对数正态 AFT 模型表现更好。多变量对数正态 AFT 模型的结果表明,年龄、居住地、物质使用、教育状况、疾病的世卫组织临床阶段、分化簇 4(CD4 计数/mm)、功能状态、复方磺胺甲噁唑预防性治疗的使用(CPT 使用)和异烟肼均为显著因素,而性别、除结核病以外的疾病以及状态的披露则为无统计学意义的变量,在 5%的显著性水平上。

结论

目前的研究结果表明,年龄较大、物质使用、晚期世卫组织疾病临床阶段(IV 期)、卧床不起的功能状态和 CD4 计数小于 200/mm 与 HIV/TB 合并感染者的死亡生存时间较短显著相关,而接受过高等教育、来自城市居住、CPT 使用和 INH 显著增加了 TB/HIV 合并感染者的死亡生存时间。应根据这些重要因素特别关注 TB/HIV 合并感染患者,以改善他们的健康状况并延长他们的生命。HIV 阳性者比其他人更容易感染结核病。TB/HIV 合并感染患者的死亡风险很高。在所有患者中,有 79 人(21.8%)死亡。加速失效时间模型是 Cox 比例风险假设未满足的替代方案。

相似文献

1
Modeling Survival Time to Death Among TB and HIV Co-infected Adult Patients: an Institution-Based Retrospective Cohort Study.结核和艾滋病毒合并感染成人患者死亡生存时间建模:基于机构的回顾性队列研究。
J Racial Ethn Health Disparities. 2023 Aug;10(4):1616-1628. doi: 10.1007/s40615-022-01348-w. Epub 2022 Jun 13.
2
Factors Affecting Survival Rates Among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia.埃塞俄比亚西南部米赞泰皮大学教学医院成人结核病/艾滋病病毒合并感染患者生存率的影响因素
HIV AIDS (Auckl). 2020 Apr 23;12:157-164. doi: 10.2147/HIV.S242756. eCollection 2020.
3
Survival rate and predictors of mortality among TB/HIV co-infected adult patients: retrospective cohort study.结核病/艾滋病病毒合并感染成年患者的生存率和死亡预测因素:回顾性队列研究。
Sci Rep. 2022 Nov 1;12(1):18360. doi: 10.1038/s41598-022-23316-4.
4
Statistical Analysis on Determinant Factors Associated with Time to Death of HIV/TB Co-Infected Patients Under HAART at Debre Tabor Referral Hospital: An Application of Accelerated Failure Time-Shared Frailty Models.德布雷塔博尔转诊医院接受高效抗逆转录病毒治疗的艾滋病毒/结核病合并感染患者死亡时间相关决定因素的统计分析:加速失效时间共享脆弱模型的应用
HIV AIDS (Auckl). 2021 Jul 17;13:775-787. doi: 10.2147/HIV.S319745. eCollection 2021.
5
Bayesian parametric modeling of time to tuberculosis co-infection of HIV/AIDS patients at Jimma Medical Center, Ethiopia.贝叶斯参数模型在评估 HIV/AIDS 患者并发结核病时间中的应用:来自埃塞俄比亚 Jimma 医疗中心的研究。
Sci Rep. 2022 Oct 1;12(1):16475. doi: 10.1038/s41598-022-20872-7.
6
Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.2021 年在埃塞俄比亚西北部启动检测和治疗策略后,艾滋病毒合并结核病儿童的终生生存估计和死亡率预测因素;一项多中心历史随访研究。
PLoS One. 2021 Dec 21;16(12):e0258964. doi: 10.1371/journal.pone.0258964. eCollection 2021.
7
Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.预测在埃塞俄比亚西北部接受结核病治疗的结核-艾滋病毒合并感染患者的死亡率:一项回顾性队列研究。
BMC Infect Dis. 2013 Jul 1;13:297. doi: 10.1186/1471-2334-13-297.
8
Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.在埃塞俄比亚西北部贡德尔大学综合专科医院,感染结核分枝杆菌和人类免疫缺陷病毒的儿童的生存和死亡预测因素。一项回顾性随访研究。
PLoS One. 2018 May 22;13(5):e0197145. doi: 10.1371/journal.pone.0197145. eCollection 2018.
9
The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort.埃塞俄比亚西南部结核病/艾滋病毒合并感染患者中延迟接受艾滋病毒治疗的患病率及相关因素:一项回顾性观察队列研究
Infect Dis Poverty. 2016 Nov 2;5(1):96. doi: 10.1186/s40249-016-0193-y.
10
Joint clinical determinants for bivariate hematological parameter among TB/HIV co-infected adults under TB/HIV treatment in university of Gondar comprehensive specialized hospital: Retrospective panel data study.联合临床决定因素在 TB/HIV 治疗下大学贡德尔综合专科医院合并感染成人双变量血液学参数:回顾性面板数据研究。
BMC Res Notes. 2024 Jun 1;17(1):150. doi: 10.1186/s13104-024-06808-6.

引用本文的文献

1
Clinical Determinants Associated With Viral Load Count Among Adult TB/HIV Co-Infected Patients: A Linear Mixed-Effects Model Analysis.成人结核病/艾滋病病毒合并感染患者病毒载量计数的临床决定因素:线性混合效应模型分析
Adv Virol. 2025 Aug 11;2025:4514560. doi: 10.1155/av/4514560. eCollection 2025.
2
Incidence Rate, Survival Rate, and Predictors for Virological Failure Among Adult TB/HIV Coinfected Clients.成人结核病/艾滋病病毒合并感染患者的发病率、生存率及病毒学失败的预测因素
J Trop Med. 2025 Feb 15;2025:2011556. doi: 10.1155/jotm/2011556. eCollection 2025.
3
Mortality and predictors among HIV-TB co-infected patients in Ethiopia: A systematic review and meta-analysis.

本文引用的文献

1
Mental health problems and social media exposure during COVID-19 outbreak.新冠疫情期间的心理健康问题与社交媒体暴露
PLoS One. 2020 Apr 16;15(4):e0231924. doi: 10.1371/journal.pone.0231924. eCollection 2020.
2
Survival rate and mortality risk factors among TB-HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study.缅甸一家艾滋病专科医院中结核-艾滋病毒合并感染患者的生存率和死亡风险因素:一项为期 12 年的回顾性随访研究。
Int J Infect Dis. 2019 Mar;80:10-15. doi: 10.1016/j.ijid.2018.12.008. Epub 2018 Dec 17.
3
Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
埃塞俄比亚艾滋病毒与结核病合并感染患者的死亡率及预测因素:一项系统评价与荟萃分析
PLoS One. 2025 Jan 6;20(1):e0317048. doi: 10.1371/journal.pone.0317048. eCollection 2025.
4
Burden of mortality and its predictors among TB-HIV co-infected patients in Ethiopia: Systematic review and meta-analysis.在埃塞俄比亚,结核-艾滋病毒合并感染患者的死亡率及其预测因素的负担:系统评价和荟萃分析。
PLoS One. 2024 Nov 7;19(11):e0312698. doi: 10.1371/journal.pone.0312698. eCollection 2024.
5
Incidence rate of mortality and its predictors among tuberculosis and human immunodeficiency virus coinfected patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis.埃塞俄比亚接受抗逆转录病毒治疗的结核病与人类免疫缺陷病毒合并感染患者的死亡率发生率及其预测因素:系统评价与荟萃分析
Front Med (Lausanne). 2024 Apr 19;11:1333525. doi: 10.3389/fmed.2024.1333525. eCollection 2024.
6
Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia.埃塞俄比亚西北部巴赫达尔市公共卫生机构中结核病治疗期间结核-艾滋病毒合并感染患者的生存率及死亡率预测因素
Infect Drug Resist. 2024 Apr 9;17:1385-1395. doi: 10.2147/IDR.S446020. eCollection 2024.
7
Prevalence and factors associated with condom use among women aged 15-49 years in Rwanda using a survey logistic regression model: evidence from the 2019/20 Rwanda Demographic and Health Survey.运用调查逻辑回归模型分析卢旺达15至49岁女性使用避孕套的流行情况及相关因素:来自2019/20卢旺达人口与健康调查的证据
Pan Afr Med J. 2023 Dec 28;46:121. doi: 10.11604/pamj.2023.46.121.41640. eCollection 2023.
8
Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: retrospective cohort study.在戈达大学综合专科医院接受抗逆转录病毒治疗的 HIV 阳性成年人中病毒载量抑制的预测因素:回顾性队列研究。
Sci Rep. 2024 Feb 8;14(1):3258. doi: 10.1038/s41598-024-53569-0.
9
Survival rate and predictors of mortality among TB/HIV co-infected adult patients: retrospective cohort study.结核病/艾滋病病毒合并感染成年患者的生存率和死亡预测因素:回顾性队列研究。
Sci Rep. 2022 Nov 1;12(1):18360. doi: 10.1038/s41598-022-23316-4.
预测结核病/艾滋病病毒合并感染患者在结核病治疗期间死亡率的预后评分。
PLoS One. 2018 Apr 16;13(4):e0196022. doi: 10.1371/journal.pone.0196022. eCollection 2018.
4
Survival Rates among Co-infected Patients with Human Immunodeficiency Virus/Tuberculosis in Tehran, Iran.伊朗德黑兰人类免疫缺陷病毒/结核病合并感染患者的生存率
Iran J Public Health. 2017 Aug;46(8):1123-1131.
5
Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia.埃塞俄比亚阿姆哈拉地区HIV感染患者中结核病/HIV合并感染的患病率及相关因素
Afr Health Sci. 2016 Jun;16(2):588-95. doi: 10.4314/ahs.v16i2.29.
6
Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.在埃塞俄比亚健康中心接受结核病调查的艾滋病毒呈阳性的男性和女性中与早期死亡率相关的因素
PLoS One. 2016 Jun 7;11(6):e0156602. doi: 10.1371/journal.pone.0156602. eCollection 2016.
7
Tuberculosis trends over a five-year period at a tertiary care university-affiliated hospital in Singapore.新加坡一所大学附属医院五年间的结核病发病趋势。
Singapore Med J. 2015 Sep;56(9):502-5. doi: 10.11622/smedj.2015134.
8
Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).喀麦隆雅温得中心医院HIV合并感染患者结核病治疗期间死亡的相关因素:一项基于医院的8年回顾性队列研究(2006 - 2013年)
PLoS One. 2014 Dec 15;9(12):e115211. doi: 10.1371/journal.pone.0115211. eCollection 2014.
9
Delays in care seeking, diagnosis and treatment among pulmonary tuberculosis patients in Shenzhen, China.中国深圳肺结核患者在寻求医疗、诊断和治疗方面的延误。
Int J Tuberc Lung Dis. 2013 May;17(5):615-20. doi: 10.5588/ijtld.12.0231.
10
Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a retrospective longitudinal study.在埃塞俄比亚接受抗逆转录病毒治疗的 HIV 感染患者中,CD4 淋巴细胞计数和体重变化的预测因素:一项回顾性纵向研究。
PLoS One. 2013;8(4):e58595. doi: 10.1371/journal.pone.0058595. Epub 2013 Apr 3.